Comparison of Biphozyl® and Phoxilium® as a Replacement Fluid During CVVH for AKI in Adults and Their Effects on pH-, Bicarbonate-levels and Respiratory Situation

Conditions

• Critically Ill
• Acute Kidney Injury
• Renal Replacement Therapy
• Continuous Renal Replacement Therapy
• Continuous Veno-Venous Hemofiltration
• Replacement Fluid
• Phoxilium
• Biphozyl
• Anticoagulation
• Regional Citrate Anticoagulation

Interventions

• DRUG: CVVH with Phoxilium® in the first 48h after randomization
• DRUG: CVVH with Biphozyl® in the first 48h after randomization
• DRUG: CVVH with Phoxilium® in the second 48h after randomization (after previous 48h with Biphozyl®)
• DRUG: CVVH with Biphozyl® in the second 48h after randomization (after previous 48h with Phoxilium®)

Sponsor

Medical University Innsbruck